|
1
|
Gatenby C and Simpson P: Menopause:
Physiology, definitions, and symptoms. Best Pract Res Clin
Endocrinol Metab. 38:1018552024. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gersh FL, O'Keefe JH and Lavie CJ:
Postmenopausal hormone therapy for cardiovascular health: The
evolving data. Heart. 107:1115–1122. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li H, Sun R, Chen Q, Guo Q, Wang J, Lu L
and Zhang Y: Association between HDL-C levels and menopause: A
meta-analysis. Hormones (Athens). 20:49–59. 2021. View Article : Google Scholar :
|
|
4
|
Chen Y, Wang A, Zhang X, Xia F and Zhao X:
Effect of age at menopause and menopause itself on high sensitivity
C-reactive protein, pulse wave velocity, and carotid intima-media
thickness in a Chinese population. Medicine (Baltimore).
102:e356292023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Witteman JC, Grobbee DE, Kok FJ, Hofman A
and Valkenburg HA: Increased risk of atherosclerosis in women after
the menopause. BMJ. 298:642–644. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zaydun G, Tomiyama H, Hashimoto H, Arai T,
Koji Y, Yambe M, Motobe K, Hori S and Yamashina A: Menopause is an
independent factor augmenting the age-related increase in arterial
stiffness in the early postmenopausal phase. Atherosclerosis.
184:137–142. 2006. View Article : Google Scholar
|
|
7
|
Colditz GA, Willett WC, Stampfer MJ,
Rosner B, Speizer FE and Hennekens CH: Menopause and the risk of
coronary heart disease in women. N Engl J Med. 316:11051987.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Talaulikar V: Menopause transition:
Physiology and symptoms. Best Pract Res Clin Obstet Gynaecol.
81:3–7. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee E, Anselmo M, Tahsin CT, Vanden Noven
M, Stokes W, Carter JR and Keller-Ross ML: Vasomotor symptoms of
menopause, autonomic dysfunction, and cardiovascular disease. Am J
Physiol Heart Circ Physiol. 323:H1270–H1280. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu Y and Li C: Hormone therapy and
biological aging in postmenopausal women. JAMA Netw Open.
7:e24308392024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Innes KE, Selfe TK and Vishnu A: Mind-body
therapies for menopausal symptoms: A systematic review. Maturitas.
66:135–149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu Y, Shen M, Song Q and Xie J: Biological
activities and pharmaceutical applications of polysaccharide from
natural resources: A review. Carbohydr. Polym. 183:91–101. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao Y, Xu X, Liu S, Huang L and Gu J:
Ganoderma: A cancer immunotherapy review. Front Pharmacol.
9:12172018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Liu Y, Tang Q, Zhou S, Feng J and
Chen H: Polysaccharide of Ganoderma and its bioactivities. Adv Exp
Med Biol. 1181:107–134. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou Y, Wang M, Wang Z, Qiu J, Wang Y, Li
J, Dong F, Huang X, Zhao J and Xu T: Polysaccharides from hawthorn
fruit alleviate high-fat diet-induced NAFLD in mice by improving
gut microbiota dysbiosis and hepatic metabolic disorder.
Phytomedicine. 139:1564582025. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shiao MS: Natural products of the
medicinal fungus Ganoderma lucidum: occurrence, biological
activities, and pharmacological functions. Chem Rec. 3:172–180.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sohretoglu D and Huang S: Ganoderma
lucidum polysaccharides as an anti-cancer agent. Anticancer Agents
Med Chem. 18:667–674. 2018. View Article : Google Scholar
|
|
18
|
Seweryn E, Ziała A and Gamian A:
Health-promoting of polysaccharides extracted from Ganoderma
lucidum. Nutrients. 13:27252021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Niu D, Zhang Y and Zeng XA:
Physicochemical properties, antioxidant and antiproliferative
activities of polysaccharides from Morinda citrifolia L. (Noni)
based on different extraction methods. Int J Biol Macromol.
150:114–121. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zeng P, Guo Z, Zeng X, Hao C, Zhang Y,
Zhang M, Liu Y, Li H, Li J and Zhang L: Chemical, biochemical,
preclinical and clinical studies of Ganoderma lucidum
polysaccharide as an approved drug for treating myopathy and other
diseases in China. J Cell Mol Med. 22:3278–3297. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Tang J, Gao H, Xu Y, Han Y, Shang H,
Lu Y and Qin C: Ganoderma lucidum triterpenoids and polysaccharides
attenuate atherosclerotic plaque in high-fat diet rabbits. Nutr
Metab Cardiovasc Dis. 31:1929–1938. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vitak T, Yurkiv B, Wasser S, Nevo E and
Sybirna N: Effect of medicinal mushrooms on blood cells under
conditions of diabetes mellitus. World J Diabetes. 8:187–201. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng Y, Bai L, Zhou Y, Tong R, Zeng M, Li
X and Shi J: Polysaccharides from Chinese herbal medicine for
anti-diabetes recent advances. Int J Biol Macromol. 121:1240–1253.
2019. View Article : Google Scholar
|
|
24
|
Sang T, Guo C, Guo D, Wu J, Wang Y, Wang
Y, Chen J, Chen C, Wu K, Na K, et al: Suppression of obesity and
inflammation by polysaccharide from sporoderm-broken spore of
Ganoderma lucidum via gut microbiota regulation. Carbohydr Polym.
256:1175942021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen M, Xiao D, Liu W, Song Y, Zou B, Li
L, Li P, Cai Y, Liu D, Liao Q and Xie Z: Intake of Ganoderma
lucidum polysaccharides reverses the disturbed gut microbiota and
metabolism in type 2 diabetic rats. Int J Biol Macromol.
155:890–902. 2020. View Article : Google Scholar
|
|
26
|
Baker JM, Al-Nakkash L and
Herbst-Kralovetz MM: Estrogen-gut microbiome axis: Physiological
and clinical implications. Maturitas. 103:45–53. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang M, Wen S, Zhang J, Peng J, Shen X and
Xu L: Systematic review and meta-analysis: Changes of gut
microbiota before and after menopause. Dis Markers.
2022:37673732022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu Y, Zhou Y, Mao T, Huang Y, Liang J,
Zhu M, Yao P, Zong Y, Lang J and Zhang Y: The relationship between
menopausal syndrome and gut microbes. BMC Womens Health.
22:4372022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pavlovska OM, Pavlovska KM, Heryak SM,
Khmil SV and Khmil MS: Vasomotor menopausal disorders as a possible
result of dysfunction of the microbiota-intestine-brain axis. J Med
Life. 15:234–240. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hu S, Ding Q, Zhang W, Kang M, Ma J and
Zhao L: Gut microbial beta-glucuronidase: A vital regulator in
female estrogen metabolism. Gut Microbes. 15:22367492023.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Trefts E, Gannon M and Wasserman DH: The
liver. Curr Biol. 27:R1147–R1151. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo X, Okpara ES, Hu W, Yan C, Wang Y,
Liang Q, Chiang JYL and Han S: Interactive relationships between
intestinal flora and bile acids. Int J Mol Sci. 23:83432022.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu S and Yang X: Intestinal flora plays a
role in the progression of hepatitis-cirrhosis-liver cancer. Front
Cell Infect Microbiol. 13:11401262023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lilley E, Stanford SC, Kendall DE,
Alexander SPH, Cirino G, Docherty JR, George CH, Insel PA, Izzo AA,
Ji Y, et al: ARRIVE 2.0 and the British journal of pharmacology:
Updated guidance for 2020. Br J Pharmacol. 177:3611–3616. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
36
|
Edgar RC: Search and clustering orders of
magnitude faster than BLAST. Bioinformatics. 26:2460–2461. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Edgar RC, Haas BJ, Clemente JC, Quince C
and Knight R: UCHIME improves sensitivity and speed of chimera
detection. Bioinformatics. 27:2194–2200. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shannon CE: A mathematical theory of
communication. Bell Syst Tech J. 27:379–423. 623–656. 1948.
View Article : Google Scholar
|
|
39
|
Gower JC: Some distance properties of
latent root and vector methods used in multivariate analysis.
Biometrika. 53:325–338. 1966. View Article : Google Scholar
|
|
40
|
Bray JR and Curtis JT: An ordination of
the upland forest communities of southern wisconsin. Ecol Monogr.
27:325–349. 1957. View Article : Google Scholar
|
|
41
|
Douglas GM, Maffei VJ, Zaneveld JR, Yurgel
SN, Brown JR, Taylor CM, Huttenhower C and Langille MGI: PICRUSt2
for prediction of metagenome functions. Nat Biotechnol. 38:685–688.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar
|
|
43
|
Kanehisa M, Goto S, Sato Y, Kawashima M,
Furumichi M and Tanabe M: Data, information, knowledge and
principle: Back to metabolism in KEGG. Nucleic Acids Res.
42(Database Issue): D199–D205. 2014. View Article : Google Scholar :
|
|
44
|
Parks DH, Tyson GW, Hugenholtz P and Beiko
RG: STAMP: Statistical analysis of taxonomic and functional
profiles. Bioinformatics. 30:3123–3124. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liang XL, Liang YW, Tian J, Mo FF, Pan TM,
Chen YF, Shao XQ and Li KP: Structural characterization and
oxidative stress modulation activity of an acidic
Heteropolysaccharide from Microctis folium. Carbohydr Polym.
369:1242612025. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Reppert SM and Weaver DR: Coordination of
circadian timing in mammals. Nature. 418:935–941. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Otto CM: Heartbeat: Is postmenopausal
hormone therapy a risk factor or preventative therapy for
cardiovascular disease in women? Heart. 107:1103–1105. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Anagnostis P and Stevenson JC:
Cardiovascular health and the menopause, metabolic health. Best
Pract Res Clin Endocrinol Metab. 38:1017812024. View Article : Google Scholar
|
|
49
|
Rossouw JE, Anderson GL, Prentice RL,
LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA,
Howard BV, Johnson KC, et al: Risks and benefits of estrogen plus
progestin in healthy postmenopausal women: Principal results from
the women's health initiative randomized controlled trial. JAMA.
288:321–333. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nai J, Zhang C, Shao H, Li B, Li H, Gao L,
Dai M, Zhu L and Sheng H: Extraction, structure, pharmacological
activities and drug carrier applications of Angelica sinensis
polysaccharide. Int J Biol Macromol. 183:2337–2353. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fang S, Wang T, Li Y, Xue H, Zou J, Cai J,
Shi R, Wu J and Ma Y: Gardenia jasminoides Ellis polysaccharide
ameliorates cholestatic liver injury by alleviating gut microbiota
dysbiosis and inhibiting the TLR4/NF-κB signaling pathway. Int J
Biol Macromol. 205:23–36. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ahmad R, Riaz M, Khan A, Aljamea A,
Algheryafi M, Sewaket D and Alqathama A: Ganoderma lucidum (Reishi)
an edible mushroom; a comprehensive and critical review of its
nutritional, cosmeceutical, mycochemical, pharmacological,
clinical, and toxicological properties. Phytother Res. 35:60302021.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Xiao C, Wu QP, Cai W, Tan JB, Yang XB and
Zhang JM: Hypoglycemic effects of Ganoderma lucidum polysaccharides
in type 2 diabetic mice. Arch Pharm Res. 35:1793–1801. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Xiao C, Wu Q, Zhang J, Xie Y, Cai W and
Tan J: Antidiabetic activity of Ganoderma lucidum polysaccharides
F31 down-regulated hepatic glucose regulatory enzymes in diabetic
mice. J Ethnopharmacol. 196:47–57. 2017. View Article : Google Scholar
|
|
55
|
Chang CJ, Lin CS, Lu CC, Martel J, Ko YF,
Ojcius DM, Tseng SF, Wu TR, Chen YY, Young JD and Lai HC: Ganoderma
lucidum reduces obesity in mice by modulating the composition of
the gut microbiota. Nat Commun. 6:74892015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhu K, Nie S, Li C, Lin S, Xing M, Li W,
Gong D and Xie M: A newly identified polysaccharide from Ganoderma
atrum attenuates hyperglycemia and hyperlipidemia. Int J Biol
Macromol. 57:142–150. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Jung E, Kong SY, Ro YS, Ryu HH and Shin
SD: Serum cholesterol levels and risk of cardiovascular death: A
systematic review and a dose-response meta-analysis of prospective
cohort studies. Int J Environ Res Public Health. 19:82722022.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Xiao MY, Pei WJ, Li S, Li FF, Xie P, Luo
HT, Hyun Yoo H and Piao XL: Gypenoside L inhibits hepatocellular
carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune
response. Bioorg Chem. 150:1075392024. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhao R, Chen Q and He YM: The effect of
Ganoderma lucidum extract on immunological function and identify
its anti-tumor immunostimulatory activity based on the biological
network. Sci Rep. 8:126802018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yu W, Qiu J, Chen Y, Che X and Li X:
Chrysanthemum morifolium extract improves metabolic
dysfunction-associated fatty liver disease by regulating lipid
metabolism. Sci Rep. 15:400692025. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Romanos M, Garcia Cordova JM, Villamarin
J, Pazmino Zurita JD and Acosta A: Obesity and metabolic
dysfunction-associated steatotic liver disease (MASLD): A
literature review on pathophysiology and treatment. Diabetes Obes
Metab. 28(Suppl2): S19–S30. 2026. View Article : Google Scholar
|
|
62
|
Cuthbertson DJ, Whyte M, Henney AE, Alam
U, Goff L, Fielding BA and Umpleby AM: Differential
pathophysiological drivers of susceptibility to type 2 diabetes and
metabolic dysfunction-associated steatotic liver disease: Ethnic
differences in insulin dynamics, whole-body fat metabolism, and
organ-specific lipid deposition. Obes Rev. 2026:e701042026.
View Article : Google Scholar
|
|
63
|
Servin-Uribe RI, Pérez-Jiménez J, Castaño
Tostado E, Hernández-Saavedra D and Reynoso Camacho R: Hepatic
lipids as molecular targets in obesity-associated insulin
resistance in rodent models: A systematic review and meta-analysis.
Lipids. Apr 28–2026.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Fuentes N and Silveyra P: Estrogen
receptor signaling mechanisms. Adv Protein Chem Struct Biol.
116:135–170. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
MacLeod B, Wang C, Brown LH, Borkowski E,
Nakamura MT, Wells KR, Brunt KR, Harasim-Symbor E, Chabowski A and
Mutch DM: Fads2 knockout mice reveal that ALA prevention of hepatic
steatosis is dependent on delta-6 desaturase activity. J Lipid Res.
65:1006422024. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Li Z, Zheng D, Zhang T, Ruan S, Li N, Yu
Y, Peng Y and Wang D: The roles of nuclear receptors in cholesterol
metabolism and reverse cholesterol transport in nonalcoholic fatty
liver disease. Hepatol Commun. 8:e03432023.PubMed/NCBI
|
|
67
|
Tseng HL, Yang SC, Yang SH and Shieh KR:
Hepatic circadian-clock system altered by insulin resistance,
diabetes and insulin sensitizer in mice. PLoS One. 10:e01203802015.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Eckel-Mahan K and Sassone-Corsi P:
Metabolism control by the circadian clock and vice versa. Nat
Struct Mol Biol. 16:462–467. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Gachon F, Bugianesi E, Castelnuovo G,
Oster H, Pendergast JS and Montagnese S: Potential bidirectional
communication between the liver and the central circadian clock in
MASLD. NPJ Metab Health Dis. 3:152025. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Xie J, Liu Y, Chen B, Zhang G, Ou S, Luo J
and Peng X: Ganoderma lucidum polysaccharide improves rat
DSS-induced colitis by altering cecal microbiota and gene
expression of colonic epithelial cells. Food Nutr Res. 63:
View Article : Google Scholar : 2019.
|
|
71
|
Cani PD, Depommier C, Derrien M, Everard A
and de Vos WM: Akkermansia muciniphila: Paradigm for
next-generation beneficial microorganisms. Nat Rev Gastroenterol
Hepatol. 19:625–637. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Everard A, Belzer C, Geurts L, Ouwerkerk
JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne
NM, et al: Cross-talk between Akkermansia muciniphila and
intestinal epithelium controls diet-induced obesity. Proc Natl Acad
Sci USA. 110:9066–9071. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Long J, Shi Z, Miao Z, Dong L and Yan D:
Lactobacillus murinus alleviates insulin resistance via promoting
L-citrulline synthesis. J Endocrinol Invest. 48:1005–1015. 2025.
View Article : Google Scholar
|
|
74
|
Jin X, Liu X, Wang Y, Li X, Zhang T, Li J,
Lei Z and Yang Y: The mechanism by which melatonin improves the
dysregulation of glucose and lipid metabolism in castrated female
mice. J Pineal Res. 77:e700822025. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Lennernäs H and Fager G: Pharmacodynamics
and pharmacokinetics of the HMG-CoA reductase inhibitors.
Similarities and differences. Clin Pharmacokinet. 32:403–425. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Ramsey LB, Johnson SG, Caudle KE, Haidar
CE, Voora D, Wilke RA, Maxwell WD, McLeod HL, Krauss RM, Roden DM,
et al: The clinical pharmacogenetics implementation consortium
guideline for SLCO1B1 and simvastatin-induced myopathy: 2014
update. Clin Pharmacol Ther. 96:423–428. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhou L, Wu B, Bian Y, Lu Y, Zou Y, Lin S,
Li Q and Liu C: Hepatotoxicity associated with statins: A
retrospective pharmacovigilance study based on the FAERS database.
PLoS One. 20:e03275002025. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Wang X, Li J, Wang T, Zhang Z, Li Q, Ma D,
Chen Z, Ju J, Xu H and Chen K: Associations between statins and
adverse events in secondary prevention of cardiovascular disease:
Pairwise, network, and dose-response meta-analyses of 47 randomized
controlled trials. Front Cardiovasc Med. 9:9290202022. View Article : Google Scholar : PubMed/NCBI
|
